| Ytd | 72.80% | |
| 1y | 149.54% |
| Open | 113.03 | Prev Close | 113.57 | Low | 110.28 | High | 116.64 | Mkt Cap | 126.67M |
| Vol | 412.45K | Avg Vol | 610.29K | EPS | -1.98 | P/E | -59.46 | Forward P/E | -10.17 |
| Beta | 1.10 | Short Ratio | 0.15 | Inst. Own | 24.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 17.85 | 200-d Avg | 7.12 | 1yr Est | 27.33 |
MNPR News
WILMETTE, Ill., July 22, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compa
WILMETTE, Ill., July 20, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compa
Monopar Therapeutics has evolved from early radiopharma assets into a more concrete bet with ALXN184
Monopar Therapeutics Inc. ("Monopar" or the "Company") (NASDAQ:MNPR), a clinical-sta
WILMETTE, Ill., June 30, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compa
BTIG analyst Jeet Mukherjee maintains Monopar Therapeutics (NASDAQ:MNPR) with a Buy and raises t
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Monopar Therapeutics (NASDAQ:MNPR)
Key findings presented at EAN 2026:In the subset of patients with neurologic symptoms at baseline fr
WILMETTE, Ill., June 26, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compa
Gainers Aditxt (NASDAQ:ADTX) shares increased by 151.6% to $0.05 during Tuesday's regular sessi
The mean of analysts' price targets for Monopar Therapeutics (MNPR) points to an 88.9% upside in the
WILMETTE, Ill., June 01, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compa
WILMETTE, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compan
WILMETTE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compan
WILMETTE, Ill. , April 19, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. ("Monopar" or the "Com
WILMETTE, Ill., March 27, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Compan
Ally Bridge Group NY LLC increased its position in shares of Monopar Therapeutics Inc. (NASDAQ: MNPR
WILMETTE, Ill., March 02, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopa
IONS, GPCR, MNPR and KOD more than double in 2025 as policy clarity, M&A revival and clinical wins l
Shares of Monopar Therapeutics Inc. (NASDAQ: MNPR - Get Free Report) gapped down prior to trading on
WILMETTE, Ill., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compa
WILMETTE, Ill., Nov. 09, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Compa
Monopar Therapeutics Inc. (NASDAQ: MNPR - Get Free Report) has been given an average rating of "Buy"
The average of price targets set by Wall Street analysts indicates a potential upside of 42.5% in Mo
Thursday's session saw 189 companies set new 52-week lows.
On Wednesday, 220 stocks hit new 52-week lows.
Gainers
Gainers
During Friday's session, 574 stocks hit new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 351 stocks hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
On Monday, 721 companies achieved new lows for the year.
On Friday, 431 companies hit new 52-week lows.
Before 10 a.m. ET on Thursday, 394 companies hit new 52-week highs.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday